Showing results (101-110 of 124) with videos related to
Sort By:
Pageof 13
Cancer Genomics & Proteomics|January 9, 2021
Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3Ioannis Panagopoulos, Kristin Andersen, Martine Eilert-Olsen, et al.JCO Precision Oncology|February 1, 2023
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal TumorKjetil Boye, Ludmila Gorunova, Bastian Gunawan, et al.Oncotarget|March 14, 2022
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneityLudmila Gorunova, Kjetil Boye, Ioannis Panagopoulos, et al.Cancer Genomics & Proteomics|September 9, 2018
Pyrosequencing Analysis of MGMT Promoter Methylation in MeningiomaIoannis Panagopoulos, Ludmila Gorunova, Henning Leske, et al.Frontiers in Oncology|May 20, 2026
The NFIA::CBFA2T3 identifies a molecularly defined subgroup of acute erythroid leukemia/erythroid sarcomaMarta Brunetti, Kristin Andersen, Geir Erland Tjønnfjord, et al.Cancers|July 27, 2022
Endometrial Carcinoma: Molecular Cytogenetics and Transcriptomic ProfileMarta Brunetti, Ioannis Panagopoulos, Valeria Vitelli, et al.Genes, Chromosomes & Cancer|February 14, 2013
Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulvaFrancesca Micci, Ioannis Panagopoulos, Lisbeth Haugom, et al.Scientific Reports|November 20, 2024
Cell surface marker heterogeneity in human myeloma cell lines for modeling of disease and therapyAlenka Djarmila Behsen, Toril Holien, Francesca Micci, et al.Genes, Chromosomes & Cancer|July 13, 2016
Novel fusion genes and chimeric transcripts in ependymal tumorsThale Kristin Olsen, Ioannis Panagopoulos, Ludmila Gorunova, et al.Genes, Chromosomes & Cancer|November 1, 2008
Reverse painting of microdissected chromosome 19 markers in ovarian carcinoma identifies a complex rearrangement mapFrancesca Micci, Jörg Weimer, Lisbeth Haugom, et al.Pageof 13